Antigenic Diversity and Immune Evasion by Malaria Parasites

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2004 Nov 13

PMID 15539495

Citations 63

Authors

Marcelo U Ferreira

Monica da Silva Nunes

Gerhard Wunderlich

Affiliations

Soon will be listed here.

Citing Articles

Malaria: Factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy.

Su X, Xu F, Stadler R, Teklemichael A, Wu J PLoS Pathog. 2025; 21(1):e1012853.

PMID: 39847577 PMC: 11756774. DOI: 10.1371/journal.ppat.1012853.

Routine malaria vaccination in Africa: a step toward malaria eradication?.

Sibomana O, Bukuru J, Saka S, Uwizeyimana M, Kihunyu A, Obianke A Malar J. 2025; 24(1):1.

PMID: 39757179 PMC: 11702236. DOI: 10.1186/s12936-024-05235-z.

Association of the humoral immune response with the inflammatory profile in Plasmodium vivax infections in pregnant women.

de Souza R, Dos Santos M, Gomes L, de Melo B, Separovic E, Murillo O PLoS Negl Trop Dis. 2024; 18(11):e0012636.

PMID: 39495782 PMC: 11563365. DOI: 10.1371/journal.pntd.0012636.

Identification and molecular characterization of a novel Babesia orientalis rhoptry neck protein 4 (BoRON4).

Li F, Guo J, Wang S, Han Z, Nie Z, Yu L Parasitol Res. 2024; 123(8):310.

PMID: 39207503 DOI: 10.1007/s00436-024-08328-5.

AMA1 and CSP antigen diversity in parasite isolates from southern Ghana.

Kusi K, Amoah L, Acquah F, Ennuson N, Frempong A, Ofori E Front Cell Infect Microbiol. 2024; 14:1375249.

PMID: 38808064 PMC: 11132687. DOI: 10.3389/fcimb.2024.1375249.

References

Gilbert S, Plebanski M, Gupta S, Morris J, Cox M, Aidoo M . Association of malaria parasite population structure, HLA, and immunological antagonism. Science. 1998; 279(5354):1173-7. DOI: 10.1126/science.279.5354.1173. View

Alves F, Durlacher R, Menezes M, Krieger H, Silva L, Camargo E . High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg. 2002; 66(6):641-8. DOI: 10.4269/ajtmh.2002.66.641. View

Genton B, Anders R, Taraika J, Ginny M, Mellor S, Alpers M . Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol. 1995; 17(9):493-501. DOI: 10.1111/j.1365-3024.1995.tb00920.x. View

McKenzie F, Ferreira M, Baird J, Snounou G, BOSSERT W . Meiotic recombination, cross-reactivity, and persistence in Plasmodium falciparum. Evolution. 2001; 55(7):1299-307. PMC: 2504330. DOI: 10.1111/j.0014-3820.2001.tb00652.x. View

Fried M, Duffy P . Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science. 1996; 272(5267):1502-4. DOI: 10.1126/science.272.5267.1502. View

Vogt A, Barragan A, Chen Q, Kironde F, Spillmann D, Wahlgren M . Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood. 2002; 101(6):2405-11. DOI: 10.1182/blood-2002-07-2016. View

Rajakaruna J, Carter R, Mendis K . Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka. Am J Trop Med Hyg. 1991; 45(4):479-87. DOI: 10.4269/ajtmh.1991.45.479. View

Anders R . Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol. 1986; 8(6):529-39. DOI: 10.1111/j.1365-3024.1986.tb00867.x. View

Rosenberg R, Wirtz R, Lanar D, Sattabongkot J, Hall T, Waters A . Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science. 1989; 245(4921):973-6. DOI: 10.1126/science.2672336. View

10.

Rich S, Ferreira M, Ayala F . The origin of antigenic diversity in Plasmodium falciparum. Parasitol Today. 2000; 16(9):390-6. DOI: 10.1016/s0169-4758(00)01741-5. View

11.

Jennings V, Lal A, Hunter R . Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria. Infect Immun. 1998; 66(12):5972-9. PMC: 108756. DOI: 10.1128/IAI.66.12.5972-5979.1998. View

12.

Porto M, Ferreira M, Camargo L, Premawansa S, del Portillo H . Second form in a segment of the merozoite surface protein 1 gene of Plasmodium vivax among isolates from Rondônia (Brazil). Mol Biochem Parasitol. 1992; 54(1):121-4. DOI: 10.1016/0166-6851(92)90104-r. View

13.

Rowe J, Kyes S, Rogerson S, Babiker H, Raza A . Identification of a conserved Plasmodium falciparum var gene implicated in malaria in pregnancy. J Infect Dis. 2002; 185(8):1207-11. DOI: 10.1086/339684. View

14.

Frontali C . Genome plasticity in Plasmodium. Genetica. 1994; 94(2-3):91-100. DOI: 10.1007/BF01443424. View

15.

Weber J . Interspersed repetitive DNA from Plasmodium falciparum. Mol Biochem Parasitol. 1988; 29(2-3):117-24. DOI: 10.1016/0166-6851(88)90066-7. View

16.

Hui G, Siddiqui W . Characterization of a Plasmodium falciparum polypeptide associated with membrane vesicles in the infected erythrocytes. Mol Biochem Parasitol. 1988; 29(2-3):283-93. DOI: 10.1016/0166-6851(88)90083-7. View

17.

Rowe J, Moulds J, Newbold C, MILLER L . P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 1997; 388(6639):292-5. DOI: 10.1038/40888. View

18.

Ahlborg N, Berzins K, Perlmann P . Definition of the epitope recognized by the Plasmodium falciparum-reactive human monoclonal antibody 33G2. Mol Biochem Parasitol. 1991; 46(1):89-95. DOI: 10.1016/0166-6851(91)90202-h. View

19.

Roshanravan B, Kari E, Gilman R, Cabrera L, Lee E, Metcalfe J . Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg. 2003; 69(1):45-52. View

20.

Bonelo A, Valmori D, Triponez F, Tiercy J, Mentha G, Oberholzer J . Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells. Eur J Immunol. 2000; 30(11):3079-88. DOI: 10.1002/1521-4141(200011)30:11<3079::AID-IMMU3079>3.0.CO;2-7. View